In this issue:
Isolated axial disease in PsA vs AS with psoriasis
Risk of breakthrough SARS-CoV- 2 infections in patients on immunosuppressants
Achilles enthesitis in AS linked to poorer outcomes
Smoking and alcohol correlate with less peripheral articular manifestations
Nail psoriasis common in PsA and adversely impacts disease activity
Prevalence of PsA and axial SpA in Norway and use of biologic DMARDs
Cognitive function impaired in patients with PsA
MUST: no benefit to concomitant methotrexate with ustekinumab
Inflammation after TNF inhibitor therapy risks radiographic progression in AS
Gut microbiome dysbiosis in SpA correlates with disease activity
Please login below to download this issue (PDF)